Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 594930, 8 pages
http://dx.doi.org/10.1155/2014/594930
Review Article

Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials

1Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510515, China
2Department of Internal Medicine, Nanfang Hospital of Southern Medical University, Luohu District, Guangdong 510515, China

Received 14 February 2014; Revised 29 April 2014; Accepted 29 April 2014; Published 25 May 2014

Academic Editor: Antoni Castells

Copyright © 2014 Yan-xian Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yan-xian Chen, Qiong Yang, Jun-jie Kuang, et al., “Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials,” Gastroenterology Research and Practice, vol. 2014, Article ID 594930, 8 pages, 2014. https://doi.org/10.1155/2014/594930.